The Department of Hepatopancreatobiliary (HPB) and Transplant Surgery specializes in treating benign and malignant diseases of the liver, pancreas, gallbladder and bile ducts. Diseases of the liver, pancreas, and biliary tract are relatively common and frequently require surgery as the primary form of treatment. These complex operations are best performed at a high-volume tertiary centre to achieve complete recovery and a good long-term outcome.
Our experienced team of surgeons are adept at performing complex operations of the liver, pancreas, bile duct and gallbladder. Besides providing cutting-edge surgical services to diagnose and treat our local population, we are a referral centre for the region and also a leading centre for clinical and translational research for HPB diseases.
The department sees patients at the one-stop multidisciplinary Centre for Digestive & Liver Diseases (CDLD) located at Singapore General Hospital, Block 3, Basement 1, as well as at the National Cancer Centre Singapore (NCCS).
We provide daily consultation services at the Centre for Digestive and Liver Diseases (CDLD) clinic located at Basement 1, Singapore General Hospital Block 3.
Our department supports emergency services which are available both inpatient and nationwide.
We are one of the centres participating in the national liver transplant program. Deceased-donor or living-donor liver transplantation is the best treatment option for selected patients with end-stage liver disease, and those with primary liver cancers.
The HPB department is closely integrated with other departments at SGH and National Cancer Centre Singapore. Complex cases are discussed at multi-disciplinary tumour board meetings that are specific for each disease. Cases are discussed in detail and a recommendation is made on the best treatment modality, and the sequence of treatment for patients. Weekly multi-disciplinary liver transplant meetings and rounds are held to discuss patients who may benefit from a liver transplant, and follow up care for those who have had a transplant.
We offer minimally-invasive (laparoscopic or robotic) procedures for selected patients requiring liver or pancreatic surgeries. Approximately 50% of our liver resections are performed using a minimally invasive approach. With the use of a minimally invasive approach, patients benefit from smaller incisions, allowing them a faster recovery and a shorter hospital stay.
Tags: